Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Zomedica Pharmaceuticals Corp
(NY:
ZOM
)
0.1330
+0.0029 (+2.23%)
Official Closing Price
Updated: 8:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Zomedica Pharmaceuticals Corp
< Previous
1
2
3
4
Next >
Zomedica to Present at Sidoti Virtual Investor Conference August 16-17
August 08, 2023
Via
ACCESSWIRE
Zomedica to Host Second Quarter Financial Results Call on August 10
August 04, 2023
Via
ACCESSWIRE
RedChip Launches 'Small Stocks, Big Money' Podcast
August 02, 2023
Via
ACCESSWIRE
Zomedica Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services
June 09, 2023
Via
ACCESSWIRE
Zomedica to Participate in the Lytham Partners Spring 2023 Investor Conference
May 12, 2023
Via
ACCESSWIRE
Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity
May 11, 2023
Via
ACCESSWIRE
Zomedica Exercises Option to Acquire Structured Monitoring Products
May 08, 2023
Via
ACCESSWIRE
Zomedica to Host First Quarter Financial Results Call on May 11
May 02, 2023
Via
ACCESSWIRE
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
April 18, 2023
Via
ACCESSWIRE
Zomedica Corp. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
March 31, 2023
Via
ACCESSWIRE
Zomedica Appoints New Chief Financial Officer
March 17, 2023
Via
ACCESSWIRE
Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth
March 15, 2023
Via
ACCESSWIRE
Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15
March 08, 2023
Via
ACCESSWIRE
Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022
February 09, 2023
Via
ACCESSWIRE
Zomedica Interview To Air on Bloomberg U.S. on the RedChip Money Report(R)
February 08, 2023
Via
ACCESSWIRE
RedChip CEO Dave Gentry Invited to Join Forbes Business Council
January 25, 2023
Via
ACCESSWIRE
Zomedica to Participate in the Lytham Partners Investor Select Conference
January 24, 2023
Via
ACCESSWIRE
Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies
January 18, 2023
Via
ACCESSWIRE
Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors
January 17, 2023
Via
ACCESSWIRE
Zomedica to Present at Sidoti Virtual Investor Conference January 18-19
January 11, 2023
Via
ACCESSWIRE
Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans
December 15, 2022
Via
ACCESSWIRE
Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities
November 14, 2022
Via
ACCESSWIRE
Zomedica to Present at LD Micro Main Event XV Conference
October 18, 2022
Via
ACCESSWIRE
Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference
September 28, 2022
Via
ACCESSWIRE
Zomedica Announces Launch of Free T4 Assay for Truforma(R) Diagnostic Platform
September 13, 2022
Via
ACCESSWIRE
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 12, 2022
Via
ACCESSWIRE
Zomedica (NYSE American: ZOM) Featured in Virtual Coverage of NIBA’s 148th Investment Conference
September 07, 2022
Via
Investor Brand Network
Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association
September 06, 2022
Via
ACCESSWIRE
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
August 23, 2022
Via
ACCESSWIRE
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined Revenues
August 15, 2022
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.